VSTM.NASDAQVerastem, INC

Form 4: Verastem CEO Sells Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Verastem, Inc. President and CEO, Dan Paterson, sold 4,000 shares of common stock in two transactions under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Dan Paterson, President and CEO, and a Director of Verastem, Inc. (VSTM), reported the sale of common stock.
  • The sales were executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to sell shares at a pre-determined time or price to avoid accusations of insider trading.
  • On December 10, 2025, Mr. Paterson sold 2,000 shares of common stock at a price of $10.07 per share.
  • On December 11, 2025, an additional 2,000 shares of common stock were sold at a price of $10.00 per share.
  • Following these transactions, Mr. Paterson beneficially owns 410,818 shares of Verastem, Inc. common stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged 10b5-1 plan mitigates immediate concerns about opportunistic selling based on non-public information. It's a routine disclosure for a planned transaction.

Positives

  • The sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to immediate, non-public information.

Negatives

  • An insider sale, particularly by a CEO, can sometimes be perceived negatively by the market as it may suggest a lack of confidence in the company's near-term prospects, even if pre-planned.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

Insider transactions, particularly sales, are routinely monitored by investors as potential indicators of management's perception of future company performance. While these sales were pre-planned under a 10b5-1 plan, they occur within a broader market context where investor sentiment can be influenced by such activities.

Stakeholder Impact

  • Shareholders may interpret the CEO's sale of shares as a signal, potentially influencing their perception of the company's stock value, although the 10b5-1 plan context suggests a non-discretionary sale.

Key Dates

DateDescription
12/10/2025Transaction date for the sale of 2,000 shares of common stock.
12/11/2025Transaction date for the sale of 2,000 shares of common stock.
12/12/2025Date the Form 4 was signed and filed.

Recommendation

hold

The filing details a routine, pre-planned insider stock sale under a 10b5-1 plan. While insider sales can sometimes be a negative signal, the pre-arranged nature reduces the immediate concern of opportunistic selling. This single transaction, without additional context on company performance or strategic shifts, does not provide sufficient information to warrant a change from a 'hold' position. Investors should monitor future company announcements and broader market trends for Verastem.

Keywords

Verastem, VSTM, Insider Trading, Form 4, Stock Sale, CEO, Dan Paterson, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.